141 related articles for article (PubMed ID: 12219840)
1. Comparison of the cell immunophenotype of metastatic and primary foci in stage IV-S neuroblastoma.
Nowicki M; Miśkowiak B
Folia Histochem Cytobiol; 2002; 40(3):297-303. PubMed ID: 12219840
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: preliminary report.
Nowicki M; Ostalska-Nowicka D; Miskowiak B
J Clin Pathol; 2006 Feb; 59(2):150-2. PubMed ID: 16443729
[TBL] [Abstract][Full Text] [Related]
3. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin.
Krishnan C; Twist CJ; Fu T; Arber DA
Am J Clin Pathol; 2009 Jan; 131(1):49-57. PubMed ID: 19095565
[TBL] [Abstract][Full Text] [Related]
4. Detection of bone marrow metastases of neuroblastoma with immunohistochemical staining of CD56, chromogranin A, and synaptophysin.
Park SJ; Park CJ; Kim S; Jang S; Chi HS; Kim MJ; Im HJ; Seo JJ
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):348-52. PubMed ID: 20216406
[TBL] [Abstract][Full Text] [Related]
5. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
[TBL] [Abstract][Full Text] [Related]
6. [Histological and immunohistochemical diagnosis of bone marrow metastases of neuroblastomas].
Boman F; Chastagner P; Floquet J; Sommelet D; Aymard B; Palau R; Kleinclaus I
Bull Cancer; 1991; 78(10):943-51. PubMed ID: 1768940
[TBL] [Abstract][Full Text] [Related]
7. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology.
Pagani A; Macri L; Faulkner LB; Tintori V; Paoli A; Garaventa A; Bussolati G
Diagn Mol Pathol; 2002 Jun; 11(2):98-106. PubMed ID: 12045713
[TBL] [Abstract][Full Text] [Related]
8. Are bone marrow aspirates or biopsies the preferred method to detect metastatic neuroblastoma to bone marrow?
Brodeur GM
J Pediatr Hematol Oncol; 1998; 20(4):297-8. PubMed ID: 9703000
[No Abstract] [Full Text] [Related]
9. Detection of neuroblastoma in the bone marrow: biopsy versus aspiration.
Aronica PA; Pirrotta VT; Yunis EJ; Penchansky L
J Pediatr Hematol Oncol; 1998; 20(4):330-4. PubMed ID: 9703007
[TBL] [Abstract][Full Text] [Related]
10. Detection of metastatic neuroblastoma in bone marrow biopsy specimens with an antibody to neuron-specific enolase.
Crary GS; Singleton TP; Neglia JP; Swanson PE; Strickler JG
Mod Pathol; 1992 May; 5(3):308-11. PubMed ID: 1495935
[TBL] [Abstract][Full Text] [Related]
11. Detection of substance P and its mRNA in human blast cells in childhood lymphoblastic leukaemia using immunocytochemistry and in situ hybridisation.
Nowicki M; Miśkowiak B; Ostalska-Nowicka D
Folia Histochem Cytobiol; 2003; 41(1):33-6. PubMed ID: 12705477
[TBL] [Abstract][Full Text] [Related]
12. [Significance of application of immunocytochemical detection of GD2 antigen in bone marrow in neuroblastoma patients].
Bolek-Marzec K; Balwierz W; Wieczorek A; Szewczyk K
Przegl Lek; 2010; 67(6):409-12. PubMed ID: 21344771
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow changes in neuroblastoma.
Mills AE; Bird AR
Pediatr Pathol; 1986; 5(2):225-34. PubMed ID: 3763507
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of the neuropeptides in the stellate ganglion of the water buffalo.
Nasu T; De Ocampo G; Molina HA; Tateyama S; Morimoto M
Fukuoka Igaku Zasshi; 2000 May; 91(5):116-22. PubMed ID: 10916853
[TBL] [Abstract][Full Text] [Related]
16. [N-myc status of neuroblastoma from bone marrow cells].
Brack T; Finckenstein FG; Kabisch H
Klin Padiatr; 1991; 203(4):323-7. PubMed ID: 1942939
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors.
Qualman SJ; O'Dorisio MS; Fleshman DJ; Shimada H; O'Dorisio TM
Cancer; 1992 Oct; 70(7):2005-12. PubMed ID: 1381992
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.
Hsiao RJ; Seeger RC; Yu AL; O'Connor DT
J Clin Invest; 1990 May; 85(5):1555-9. PubMed ID: 2332506
[TBL] [Abstract][Full Text] [Related]
19. Vacuolated neuroblastoma cells mimicking FAB L(3) lymphoblasts in bone marrow aspirates.
Alcasabas P; Dettore A; Ozgönenel B; Bhambhani K; Ravindranath Y; Savaşan S
Pediatr Blood Cancer; 2007 Feb; 48(2):227-9. PubMed ID: 16425244
[TBL] [Abstract][Full Text] [Related]
20. [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].
Klingebiel T; Feine U; Niethammer D; Müller-Schauenburg W; Schwabe D; Maul FD; Gerein V; Fischer M; Gahr M; Kraz K
Klin Padiatr; 1986; 198(3):230-6. PubMed ID: 3723987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]